Intuitive Surgical, Inc. (ISRG) EV/EBITDA Ratio: 35.49x
Is Intuitive Surgical, Inc.’s EV/EBITDA ratio high or low?
Intuitive Surgical, Inc.'s EV/EBITDA ratio of 35.49x is 32% below its 5-year average of 52.43x, near the low end of its 5-year range (31.63x–78.06x).
As of Thursday, June 11, 2026. 25.25% below its 12-month average of 47.48x.
ISRG EV/EBITDA Ratio Chart
ISRG Average EV/EBITDA Ratio Chart
ISRG Current vs Average EV/EBITDA Ratio Chart
ISRG EV/EBITDA Ratio Metrics
EV/EBITDA RATIO
35.49x
EV/EBITDA RATIO AVG TTM
47.48x
EV/EBITDA RATIO AVG 3Y
54.45x
EV/EBITDA RATIO AVG 5Y
52.43x
EV/EBITDA RATIO AVG 10Y
47.20x
EV/EBITDA RATIO AVG 15Y
38.76x
EV/EBITDA RATIO AVG 20Y
36.90x
CURRENT VS TTM AVG
-25.25%
CURRENT VS 3Y AVG
-34.83%
CURRENT VS 5Y AVG
-32.31%
CURRENT VS 10Y AVG
-24.81%
CURRENT VS 15Y AVG
-8.45%
CURRENT VS 20Y AVG
-3.81%
ISRG Competitors' EV/EBITDA Ratio
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Intuitive Surgical, Inc. (ISRG) | $144.79B | 35.49x | 47.48x | 54.45x | 52.43x |
| Pfizer Inc. (PFE) | $149.61B | 12.74x | 10.53x | 15.94x | 13.74x |
| Abbott Laboratories (ABT) | $155.75B | 17.53x | 18.77x | 19.31x | 18.59x |
| Gilead Sciences, Inc. (GILD) | $156.35B | 12.52x | 14.17x | 17.98x | 15.97x |
| CVS Health Corporation (CVS) | $126.70B | 17.44x | 14.88x | 11.86x | 12.00x |
| Danaher Corporation (DHR) | $126.39B | 21.58x | 23.48x | 23.88x | 22.36x |
| Bristol-Myers Squibb Company (BMY) | $116.13B | 10.99x | 9.65x | 16.59x | 15.47x |
| Thermo Fisher Scientific Inc. (TMO) | $176.21B | 19.44x | 19.75x | 20.47x | 20.32x |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.59B | 21.06x | 22.98x | 82.22x | 54.95x |
| Medtronic plc (MDT) | $102.72B | 13.03x | 15.68x | 15.65x | 17.02x |
EV/EBITDA vs. its own history
At 35.5, EV/EBITDA is in its normal range, sitting higher than 50% of its 20-year history.
20-year low
9.3
median
35.8
20-year high
78.1
Intuitive Surgical, Inc. EV/EBITDA Ratio Formula & Definition
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Intuitive Surgical, Inc. EV/EBITDA Ratio FAQ
- What is the EV/EBITDA ratio for Intuitive Surgical, Inc. (ISRG)?
- The EV/EBITDA ratio for ISRG stock is 35.49x.
- Is Intuitive Surgical, Inc.'s EV/EBITDA ratio high or low?
- Intuitive Surgical, Inc.'s EV/EBITDA ratio of 35.49x is 32% below its 5-year average of 52.43x, near the low end of its 5-year range (31.63x–78.06x).
- What is the TTM average EV/EBITDA ratio for Intuitive Surgical, Inc. (ISRG)?
- The TTM average EV/EBITDA ratio for ISRG stock is 47.48x.
- What is the 3Y average EV/EBITDA ratio for Intuitive Surgical, Inc. (ISRG)?
- The 3Y average EV/EBITDA ratio for ISRG stock is 54.45x.
- What is the 5Y average EV/EBITDA ratio for Intuitive Surgical, Inc. (ISRG)?
- The 5Y average EV/EBITDA ratio for ISRG stock is 52.43x.
- What is the 10Y average EV/EBITDA ratio for Intuitive Surgical, Inc. (ISRG)?
- The 10Y average EV/EBITDA ratio for ISRG stock is 47.20x.
- What is the 15Y average EV/EBITDA ratio for Intuitive Surgical, Inc. (ISRG)?
- The 15Y average EV/EBITDA ratio for ISRG stock is 38.76x.
- What is the 20Y average EV/EBITDA ratio for Intuitive Surgical, Inc. (ISRG)?
- The 20Y average EV/EBITDA ratio for ISRG stock is 36.90x.
Intuitive Surgical, Inc. EV/EBITDA Ratio History
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-06-10 | 35.49x |
| 2026-06-09 | 36.77x |
| 2026-06-08 | 36.07x |
| 2026-06-05 | 36.37x |
| 2026-06-04 | 36.09x |
| 2026-06-03 | 35.08x |
| 2026-06-02 | 34.64x |
| 2026-06-01 | 35.51x |
| 2026-05-29 | 36.59x |
| 2026-05-28 | 36.51x |
| 2026-05-27 | 36.06x |
| 2026-05-26 | 37.64x |
| 2026-05-22 | 37.77x |
| 2026-05-21 | 37.92x |
| 2026-05-20 | 38.72x |
| 2026-05-19 | 38.07x |
| 2026-05-18 | 37.93x |
| 2026-05-15 | 36.29x |
| 2026-05-14 | 36.89x |
| 2026-05-13 | 37.26x |
| 2026-05-12 | 37.23x |
| 2026-05-11 | 36.19x |
| 2026-05-08 | 38.81x |
| 2026-05-07 | 39.11x |
| 2026-05-06 | 38.96x |
| 2026-05-05 | 38.93x |
| 2026-05-04 | 39.01x |
| 2026-05-01 | 39.49x |
| 2026-04-30 | 39.47x |
| 2026-04-29 | 39.14x |
| 2026-04-28 | 40.26x |
| 2026-04-27 | 40.64x |
| 2026-04-24 | 41.62x |
| 2026-04-23 | 41.33x |
| 2026-04-22 | 41.75x |
| 2026-04-21 | 40.01x |
| 2026-04-20 | 41.30x |
| 2026-04-17 | 41.63x |
| 2026-04-16 | 40.62x |
| 2026-04-15 | 41.55x |
| 2026-04-14 | 41.45x |
| 2026-04-13 | 40.70x |
| 2026-04-10 | 39.95x |
| 2026-04-09 | 40.34x |
| 2026-04-08 | 41.00x |
| 2026-04-07 | 40.16x |
| 2026-04-06 | 40.13x |
| 2026-04-02 | 40.08x |
| 2026-04-01 | 41.20x |
| 2026-03-31 | 40.89x |
| 2026-03-30 | 40.14x |
| 2026-03-27 | 40.13x |
| 2026-03-26 | 41.57x |
| 2026-03-25 | 41.70x |
| 2026-03-24 | 41.87x |
| 2026-03-23 | 42.43x |
| 2026-03-20 | 42.42x |
| 2026-03-19 | 42.60x |
| 2026-03-18 | 42.40x |
| 2026-03-17 | 42.85x |
| 2026-03-16 | 42.92x |
| 2026-03-13 | 41.90x |
| 2026-03-12 | 42.54x |
| 2026-03-11 | 43.77x |
| 2026-03-10 | 43.13x |
| 2026-03-09 | 43.83x |
| 2026-03-06 | 43.52x |
| 2026-03-05 | 44.11x |
| 2026-03-04 | 44.52x |
| 2026-03-03 | 44.18x |
| 2026-03-02 | 44.07x |
| 2026-02-27 | 44.73x |
| 2026-02-26 | 45.03x |
| 2026-02-25 | 44.97x |
| 2026-02-24 | 43.87x |
| 2026-02-23 | 43.70x |
| 2026-02-20 | 44.78x |
| 2026-02-19 | 44.37x |
| 2026-02-18 | 44.48x |
| 2026-02-17 | 43.81x |
| 2026-02-13 | 43.13x |
| 2026-02-12 | 42.48x |
| 2026-02-11 | 44.06x |
| 2026-02-10 | 43.97x |
| 2026-02-09 | 43.76x |
| 2026-02-06 | 43.34x |
| 2026-02-05 | 42.27x |
| 2026-02-04 | 42.47x |
| 2026-02-03 | 42.50x |
| 2026-02-02 | 47.22x |
| 2026-01-30 | 47.94x |
| 2026-01-29 | 48.27x |
| 2026-01-28 | 49.66x |
| 2026-01-27 | 49.95x |
| 2026-01-26 | 50.32x |
| 2026-01-23 | 49.85x |
| 2026-01-22 | 50.03x |
| 2026-01-21 | 49.82x |
| 2026-01-20 | 50.19x |
| 2026-01-16 | 50.92x |
| 2026-01-15 | 51.53x |
| 2026-01-14 | 52.05x |
| 2026-01-13 | 53.51x |
| 2026-01-12 | 54.56x |
| 2026-01-09 | 55.86x |
| 2026-01-08 | 55.75x |
| 2026-01-07 | 56.45x |
| 2026-01-06 | 56.50x |
| 2026-01-05 | 53.95x |
| 2026-01-02 | 53.52x |
| 2025-12-31 | 53.94x |
| 2025-12-30 | 54.55x |
| 2025-12-29 | 54.82x |
| 2025-12-26 | 55.05x |
| 2025-12-24 | 54.99x |
| 2025-12-23 | 55.00x |
| 2025-12-22 | 55.25x |
| 2025-12-19 | 54.53x |
| 2025-12-18 | 53.51x |
| 2025-12-17 | 53.03x |
| 2025-12-16 | 52.81x |
| 2025-12-15 | 53.28x |
| 2025-12-12 | 51.62x |
| 2025-12-11 | 52.11x |
| 2025-12-10 | 52.94x |
| 2025-12-09 | 53.15x |
| 2025-12-08 | 54.00x |
| 2025-12-05 | 54.81x |
| 2025-12-04 | 54.16x |
| 2025-12-03 | 54.27x |
| 2025-12-02 | 54.08x |
| 2025-12-01 | 54.04x |
| 2025-11-28 | 54.63x |
| 2025-11-26 | 54.70x |
| 2025-11-25 | 55.15x |
| 2025-11-24 | 54.15x |
| 2025-11-21 | 53.49x |
| 2025-11-20 | 52.58x |
| 2025-11-19 | 53.78x |
| 2025-11-18 | 52.05x |
| 2025-11-17 | 52.05x |
| 2025-11-14 | 52.32x |
| 2025-11-13 | 53.86x |
| 2025-11-12 | 54.53x |
| 2025-11-11 | 54.51x |
| 2025-11-10 | 54.89x |
| 2025-11-07 | 53.33x |
| 2025-11-06 | 52.15x |
| 2025-11-05 | 52.22x |
| 2025-11-04 | 51.28x |
| 2025-11-03 | 51.81x |
| 2025-10-31 | 50.85x |
| 2025-10-30 | 50.43x |
| 2025-10-29 | 51.17x |
| 2025-10-28 | 51.92x |
| 2025-10-27 | 52.49x |
| 2025-10-24 | 52.03x |
| 2025-10-23 | 52.49x |
| 2025-10-22 | 50.15x |
| 2025-10-21 | 46.92x |
| 2025-10-20 | 46.48x |
| 2025-10-17 | 45.20x |
| 2025-10-16 | 44.01x |
| 2025-10-15 | 44.11x |
| 2025-10-14 | 44.19x |
| 2025-10-13 | 44.12x |
| 2025-10-10 | 43.49x |
| 2025-10-09 | 44.95x |
| 2025-10-08 | 45.40x |
| 2025-10-07 | 44.66x |
| 2025-10-06 | 45.57x |
| 2025-10-03 | 45.84x |
| 2025-10-02 | 44.88x |
| 2025-10-01 | 44.36x |
| 2025-09-30 | 45.31x |
| 2025-09-29 | 44.48x |
| 2025-09-26 | 44.68x |
| 2025-09-25 | 44.37x |
| 2025-09-24 | 44.98x |
| 2025-09-23 | 45.37x |
| 2025-09-22 | 45.04x |
| 2025-09-19 | 44.43x |
| 2025-09-18 | 44.13x |
| 2025-09-17 | 43.91x |
| 2025-09-16 | 44.00x |
| 2025-09-15 | 43.94x |
| 2025-09-12 | 45.57x |
| 2025-09-11 | 46.20x |
| 2025-09-10 | 45.60x |
| 2025-09-09 | 47.41x |
| 2025-09-08 | 47.67x |
| 2025-09-05 | 47.34x |
| 2025-09-04 | 46.07x |
| 2025-09-03 | 44.69x |
| 2025-09-02 | 47.57x |
| 2025-08-29 | 48.01x |
| 2025-08-28 | 48.07x |
| 2025-08-27 | 47.79x |
| 2025-08-26 | 48.11x |
| 2025-08-25 | 47.51x |
| 2025-08-22 | 48.31x |
| 2025-08-21 | 47.66x |
| 2025-08-20 | 48.75x |
| 2025-08-19 | 48.62x |
| 2025-08-18 | 48.84x |
| 2025-08-15 | 48.73x |
| 2025-08-14 | 48.40x |
| 2025-08-13 | 48.95x |
| 2025-08-12 | 48.52x |
| 2025-08-11 | 47.86x |
| 2025-08-08 | 47.68x |
| 2025-08-07 | 47.65x |
| 2025-08-06 | 48.09x |
| 2025-08-05 | 48.39x |
| 2025-08-04 | 49.05x |
| 2025-08-01 | 49.03x |
| 2025-07-31 | 48.82x |
| 2025-07-30 | 50.83x |
| 2025-07-29 | 50.45x |
| 2025-07-28 | 50.15x |
| 2025-07-25 | 50.35x |
| 2025-07-24 | 49.59x |
| 2025-07-23 | 50.98x |
| 2025-07-22 | 55.72x |
| 2025-07-21 | 56.29x |
| 2025-07-18 | 56.56x |
| 2025-07-17 | 56.29x |
| 2025-07-16 | 55.90x |
| 2025-07-15 | 55.86x |
| 2025-07-14 | 56.32x |
| 2025-07-11 | 55.84x |
| 2025-07-10 | 57.39x |
| 2025-07-09 | 57.62x |
| 2025-07-08 | 57.52x |
| 2025-07-07 | 58.34x |
| 2025-07-03 | 59.42x |
| 2025-07-02 | 58.99x |
| 2025-07-01 | 58.71x |
| 2025-06-30 | 59.31x |
| 2025-06-27 | 58.23x |
| 2025-06-26 | 58.29x |
| 2025-06-25 | 56.90x |
| 2025-06-24 | 57.06x |
| 2025-06-23 | 56.17x |
| 2025-06-20 | 55.54x |
| 2025-06-18 | 55.55x |
| 2025-06-17 | 55.84x |
| 2025-06-16 | 56.61x |
| 2025-06-13 | 55.85x |
| 2025-06-12 | 55.94x |
| 2025-06-11 | 56.98x |
| 2025-06-10 | 57.78x |
| 2025-06-09 | 57.40x |
| 2025-06-06 | 60.82x |
| 2025-06-05 | 60.93x |
| 2025-06-04 | 60.91x |
| 2025-06-03 | 60.24x |
| 2025-06-02 | 60.40x |
| 2025-05-30 | 60.29x |
| 2025-05-29 | 60.67x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David J. Rosa